|
|
Volumn 15, Issue 11, 2016, Pages 731-732
|
|
Patients as key partners in rare disease drug development
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
CROSS-SECTIONAL STUDY;
DISEASE COURSE;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG INFORMATION;
DRUG LEGISLATION;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SCREENING;
FOOD AND DRUG ADMINISTRATION;
HEALTH SURVEY;
HUMAN;
METHODOLOGY;
NOTE;
PATIENT CARE;
PATIENT PARTICIPATION;
PRIORITY JOURNAL;
PROGRAM DEVELOPMENT;
RARE DISEASE;
RISK BENEFIT ANALYSIS;
STANDARDIZATION;
SYMPTOM;
CLINICAL TRIAL (TOPIC);
PROCEDURES;
RARE DISEASES;
CLINICAL TRIALS AS TOPIC;
DRUG DISCOVERY;
HUMANS;
PATIENT PARTICIPATION;
RARE DISEASES;
|
|
EID: 84979300814
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2016.133 Document Type: Note |
|
Times cited : (19)
|
|
References (4)
|
